Trial Profile
Double-blind, Randomized, Placebo-controlled, Phase III Study Comparing norUrsodeoxycholic Acid Capsules With Placebo in the Treatment of Primary Sclerosing Cholangitis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2024
Price :
$35
*
At a glance
- Drugs Norursodeoxycholic acid (Primary)
- Indications Primary sclerosing cholangitis
- Focus Registrational; Therapeutic Use
- Sponsors Dr Falk Pharma
- 10 Jan 2024 This trial has been completed in Belgium.
- 24 Jun 2023 Baseline characteristics of patients included in this study, presented at the European Association for the Study of the Liver Congress 2023
- 14 Jul 2022 This trial has been discontinued in Czechia, according to European Clinical Trials Database record.